24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Burns
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:19
Trump's policy creates a window of opportunity for Israel in AI
11:14
Intel says upcoming layoffs will be less than 20,000—but early retirement won’t be an option
10:31
How AI agents will transform work — and what humans must do to stay relevant
09:59
Intel-backed Ignite DeepTech launches first cohort in Israel
More stories
Buzz
Most popular
Daily
Weekly
1
Intel says upcoming layoffs will be less than 20,000—but early retirement won’t be an option
2
Intel cancels Intel Capital spinoff as Lip-Bu Tan shifts to financial discipline
3
Intel’s AI reset highlights hard lessons from Israeli acquisitions
4
Adam Neumann’s Flow raises over $100M at $2.5B valuation
5
Inside the Intel reckoning: layoffs, leadership, and the long road back to relevance
More news
Burns
4 stories about Burns
MediWound to supply pineapple-based burn treatment to UAE's Ghassan Aboud Group
15.12.20
|
CTech
"GAG, through its healthcare arm, has extensive knowledge and experience in wound care and has a strong reach into the major clinical institutions in the UAE," said Sharon Malka, CEO of MediWound
MediWound to Supply Pineapple-Based Burn Treatment to U.S. Department of Health
07.01.20
|
Tzally Greenberg
The company’s product NexoBrid is a pineapple enzyme-based topical treatment for the removal of dead tissue from burn wounds
CEO of Burn Treatment Company MediWound Steps Down
14.03.19
|
CTech
Following a 12-year tenure, Gal Cohen will be replaced by the company’s current chief financial officer Sharon Malka in late May
MediWound’s Pineapple-Based Burn Treatment to Treat Mustard Gas Burns
31.05.18
|
Dror Reich
The Nasdaq-listed, Israeli based company received the FDA’s approval to expand the use of flagship burn treatment NexoBrid to those suffering from Sulfur Mustard injuries